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Abstract
Objectives—This study examined the main and interactive effects of MDD and lifetime 
nonsuicidal self-injury (NSSI) on current suicide risk and past suicide attempts. We predicted that 
individuals with a history of NSSI and current MDD would be at greater suicide risk than those 
with either risk factor alone. An interaction between lifetime MDD and NSSI was hypothesized 
for past suicide attempts.
Methods—204 substance dependent inpatients completed self-report measures and a diagnostic 
interview.
Results—Patients with both a history of NSSI and current MDD, relative to all other groups, had 
the greatest suicide risk. No support was found for the lifetime MDD by NSSI interaction.
Conclusion—Findings suggest the relevance of both NSSI and MDD in suicide risk.
Keywords
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Suicidality is a substantial public health concern, with suicide accounting for over 41,000 
deaths per year in the United States (Centers for Disease Control, 2013) and costing 
hundreds of billions of dollars each year (Institute of Medicine, 2002). As such, research 
identifying the risk factors for lethal and non-lethal suicidal behavior, defined as deliberate 
self-directed violence with at least some intent to die (Crosby, Buckner, & Taylor, 2011), is 
an urgent health priority. One well-established risk factor for suicidal behavior is major 
depressive disorder (MDD). Studies have demonstrated that individuals with (vs. without) 
mood disorders in general are at heightened risk for suicide (Kessler, Borges, & Walters, 
1999; Nock et al., 2009; World Health Organization, 2001). In addition, individuals with a 
history of MDD have been found to have higher rates of death by suicide and suicide 
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attempts, as well as higher levels of suicidal ideation than individuals without this diagnosis 
(Kessler, Berglund, Borges, Nock, & Wang, 2005; Neeleman, 2001; Nock, Hwang, 
Sampson, & Kessler, 2010). Indeed, up to 32% of individuals who die by suicide suffer from 
MDD (Foster, Gillespie, McClelland, & Patterson, 1999; Vijayakumar & Rajkumar, 1999). 
Yet, despite strong evidence for a robust relation between MDD and suicidal behavior, many 
individuals with MDD do not attempt suicide (Verona, Sachs-Ericsson, & Joiner, 2004). 
Consequently, there is a need to identify factors that may increase the risk for suicidal 
behaviors among individuals with MDD.
One factor that warrants consideration is nonsuicidal self-injury (NSSI), defined as the 
deliberate, direct, self-inflicted destruction of body tissue without suicidal intent and for 
purposes not socially sanctioned (Gratz, 2001; International Society for the Study of Self-
Injury, 2007; Klonsky, Oltmanns, & Turkheimer, 2003; Pattison & Kahan, 1983). Although 
considered distinct from suicidal behavior (Brausch & Gutierrez, 2010; Muehlenkamp & 
Gutierrez, 2004; Plener, Libal, Keller, Fegert, & Muehlenkamp, 2009), NSSI has been found 
to co-occur commonly with suicidal behaviors among both adults and adolescents (Asarnow 
et al., 2011; Klonsky & Muehlenkamp, 2007; Nock, Joiner, Gordon, Lloyd-Richardson, & 
Prinstein, 2006). Furthermore, there is evidence that NSSI is a robust risk factor for future 
suicidal behavior (Guan, Fox, & Prinstein, 2012; Klonsky, May, & Glenn, 2013; Tang et al., 
2011; Wilkinson, Kelvin, Roberts, Dubicka, Goodyer, 2011).
Although extant literature provides support for the roles of both MDD and NSSI in suicidal 
behavior, less is known about how MDD and NSSI interact to influence suicidal behavior 
and suicide risk. According to the interpersonal psychological theory of suicidal behavior 
(IPTS; Joiner, 2005), suicidal behavior requires two elements: (1) the capacity for suicidal 
behavior and (2) the desire to die by suicide. With regard to the first component, although 
recent research suggests a sizable portion of this variable is accounted for by genetic factors 
(Smith et al., 2012), the IPTS posits that individuals must acquire the capability for suicide 
through repeated engagement in and/or exposure to painful or provocative events, which, in 
turn, results in habituation to physiological pain and fear of death/bodily harm. Theoretical 
and empirical literature demonstrate that engagement in NSSI is a particularly robust path 
toward acquiring this capacity (Joiner, 2005; Franklin, Aaron, Arthur, Shorkey, & Prinstein, 
2012; Nock et al., 2006; Van Orden, Witte, Gordon, Bender, & Joiner, 2008). As for the 
second component of the IPTS (i.e., the desire to die by suicide), suicidal desire is a 
common feature of depressive episodes (Joiner, 2005) and depression severity has 
demonstrated strong associations with suicidal ideation (Genischen, Teising, Konig, Gerlach, 
& Petersen, 2010; Keilp et al., 2012), although not necessarily with suicide attempts (e.g., 
van Gastel, Schotte, & Maes, 1997). Thus, NSSI and MDD may capture both components of 
the IPTS, with the interaction between NSSI and MDD representing the interaction of 
acquired capability and suicidal desire posited in the IPTS (and found in past studies; e.g., 
Anestis & Joiner, 2011; Joiner et al., 2009). Notably, although no studies have directly 
examined the interaction of NSSI and MDD in suicide risk or suicidal behaviors, past 
research provides indirect support for the proposed model, finding a positive association 
between depressive symptoms and suicidal behavior among individuals with a history of 
NSSI (Muehlenkamp & Gutierrez, 2007).
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Given the absence of research on the interrelations of NSSI and MDD in suicide risk, and 
consistent with recent recommendations within the field of suicidology to focus less on main 
effect models and more on the ways in which specific risk factors interact to influence 
various aspects of suicide risk (e.g., ideation vs. behavior; Klonsky & May, 2014), this study 
sought to extend extant research by examining the interactive effects of NSSI and MDD on 
suicide-related outcomes (both current suicide risk and past suicide attempts) within an at-
risk sample of substance dependent patients. Specifically, substance dependent patients have 
been found to exhibit heightened rates of suicidal behaviors (Anestis, Tull, Bagge, & Joiner, 
2012; Bornovalova, Tull, Gratz, Levy, & Lejuez, 2011), NSSI (Bornovalova et al., 2011; 
Gratz & Tull, 2010), and MDD (for a review, see Armstrong & Costello, 2002), as well as 
elevated levels of suicide risk (Beautrais et al., 1996; Cheng, Chen, Chen, & Jenkins, 2000; 
Nock et al., 2009). We hypothesized that lifetime NSSI and current MDD would interact to 
predict current suicide risk (defined as the totality of past suicidal behavior and current 
suicidal thoughts, plans, and preparations; see Beck, Brown, Steer, Dahlsgaard, & Grisham, 
1999; Joiner et al., 2005; Joiner & Rudd, 2000; Lewinsohn, Rohde, & Seely, 1996), such 
that individuals with a history (i.e., lifetime) of NSSI and current (i.e., past month) MDD 
would be at higher risk for suicide than individuals with either risk factor alone. These 
particular timeframes (i.e., current MDD and lifetime NSSI) were chosen in the model 
examining current suicide risk because they correspond most closely to the components of 
the IPTS model and ideation-to-action framework (Klonsky & May, 2015). Specifically, 
whereas acute suicidal desire is best captured by current MDD, the acquired capability for 
suicide is best captured by lifetime NSSI (given that the acquired capability for suicide is 
expected to develop gradually over time through repeated exposure to painful and 
provocative events; Joiner, 2005).
Likewise, we hypothesized that lifetime NSSI and lifetime MDD would interact to predict 
past suicidal behaviors, such that individuals with a history of both MDD and NSSI would 
be most likely to report a history of suicide attempts. Lifetime MDD was selected over 
current MDD in this model due to the focus on lifetime suicide attempts and the greater 
applicability of historical experiences of depression to historical suicidal behaviors (as 




Participants were 204 substance dependent patients (51% female) consecutively admitted to 
a residential SUD treatment program in central Mississippi. Participants ranged in age from 
18 to 65, with an average age of 35 (SD = 10.29). In regard to their racial/ethnic background, 
60.8% identified as White, 36.3% as Black/African-American, 1.5% as Latino/Latina, and 
1.5% as another racial/ethnic background. The majority of participants were single (75%) 
and low-income (67% < $20,000 yearly income). Approximately 72% were unemployed. 
With regard to their educational attainment, 28% had not completed high school or received 
a GED, 33% had completed high school or received a GED, 29% had attended at least some 
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college or technical school, and 10% had graduated college. Information on the psychiatric 
diagnoses of participants is presented in Table 1.
Measures
Clinical Interviews—The Mini International Neuropsychiatric Interview, Version 6.0 
(MINI; Sheehan, Janays, Harnett-Sheehan, Sheehan, & Gray, 2009) was used to assess for 
current DSM-IV Axis I disorders (with the exception of posttraumatic stress disorder), 
including MDD. Lifetime MDD was also assessed. The MINI has shown adequate reliability 
and validity in its assessment of psychiatric disorders, as well as strong test-retest and inter-
rater reliability (Sheehan et al., 1997).
The MINI was also used to assess current (past month) suicide risk and suicide attempt 
history, consistent with past studies that have used similar clinician-rated measures of 
suicide risk to evaluate the IPTS (Van Orden et al., 2008). Specifically, the MINI includes 11 
items aimed at assessing a variety of suicide risk factors within the past month that increase 
the risk for imminent suicidal behavior. These items assess constructs related to current 
ambivalent and clear suicidal desire (i.e., experience of an accident where an individual had 
an intent to hurt themselves or die, hopelessness, thoughts of being better off dead, a desire 
to harm oneself, and thoughts about suicide), current plans and preparations for suicide (i.e., 
presence of a suicide plan, taking steps to prepare to injure or kill oneself), recent and 
lifetime self-injurious behaviors (i.e., past month NSSI, past month suicide attempts, and 
lifetime suicide attempts), and current difficulties controlling impulses to end one’s life. 
Each item is accompanied by a particular point value. Values associated with endorsed items 
are then summed to provide a score representing suicide risk within the past month. Suicide 
risk scores can range from 0 (no risk) to 52 (high suicide risk). Previous studies have 
demonstrated that the MINI suicidal risk index predicts suicidal behaviors over the course of 
one year (Roaldset, Linaker, & Bjørkly, 2012). Due to the possible criterion contamination 
between current suicide risk on the MINI and both MDD and NSSI, items assessing 
hopelessness and NSSI in the past month were excluded from the suicide risk score. The 
unadjusted and adjusted suicide risk scores were highly correlated (r = .97, p < .001). Within 
this sample, internal consistency of the suicide risk item of the MINI was adequate (α = .
81). History of a suicide attempt (presence vs. absence) was determined by using the 
lifetime suicide attempt question from the MINI (i.e., item 11 for assessing suicide risk).
The Clinician-Administered PTSD Scale (CAPS; Blake et al., 1990) was used to assess 
current PTSD. Evidence for the reliability and validity of the CAPS in a variety of samples, 
including SUD patients, has been provided (e.g., Blake et al., 1990; Brown, Stout, & 
Mueller, 1996; Shalev, Freedman, Peri, Brandes, & Sahar, 1997; Weathers, Keane, & 
Davidson, 2001). Finally, participants were interviewed using the borderline personality 
disorder module of the Diagnostic Interview for DSM-IV Personality Disorders (DIPD-IV; 
Zanarini, Frankenburg, Sickel, & Yong, 1996), a structured diagnostic interview of DSM-IV 
Axis II disorders. The DIPD-IV has been found to demonstrate good inter-rater and test-
retest reliability (Zanarini et al., 2000). All interviews were conducted by bachelors- or 
masters-level clinical assessors trained by the principal investigator (MTT) and co-
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investigator (KLG). All interviews were reviewed by the principal investigator, with 
diagnoses confirmed in consensus meetings.
Measure of NSSI—History of NSSI was assessed using the Deliberate Self-Harm 
Inventory (DSHI; Gratz, 2001), a 17-item questionnaire that assesses lifetime history of 
various aspects of NSSI, including frequency, duration, and type of DSH behavior (including 
cutting, burning, carving, bone-breaking, biting, and head-banging, among others). 
Specifically, the DSHI asks participants whether and how often they have engaged in a 
variety of behaviors “intentionally (i.e., on purpose),” as well as the last time they engaged 
in each of the behaviors. For the one behavior that could also be used to end one’s life 
(cutting), participants are asked whether they have cut themselves “without intending to kill 
yourself.” In addition, participants are instructed to exclude behaviors they engaged in with 
the sole purpose of delivering substances, especially in regard to the item, “Have you ever 
intentionally (i.e., on purpose) stuck sharp objects such as needles, pins, staples, etc. into 
your skin.” The DSHI has demonstrated high internal consistency, adequate test-retest 
reliability, and adequate construct, discriminant, and convergent validity among 
undergraduate student and patient samples (Fliege et al., 2006; Gratz, 2001). Internal 
consistency of the DSHI in this sample was adequate (α = .70). Consistent with past 
research examining the factors associated with NSSI among various populations, including 
SUD patients, a dichotomous NSSI variable was created by assigning a score of “1” to 
participants who reported having engaged in NSSI, and a score of “0” to participants who 
did not report having engaged in any of the behaviors on the DSHI (for a comparable 
approach to examining NSSI, see Evren, Jural, & Cakmak, 2006; Heath, Toste, Nedecheva, 
& Charlebois, 2008; Klonsky et al., 2003; Muehlenkamp & Gutierrez, 2004; Polk & Liss, 
2007).
Procedure
All procedures were reviewed and approved by the relevant Institutional Review Boards. 
Data were collected as part of a larger study examining risky behaviors among SUD 
patients. To be eligible for inclusion in the larger study, participants were required to: 1) be 
dependent on cocaine and/or alcohol; 2) have a Mini-Mental Status Exam (Folstein, 
Folstein, & McHugh, 1975) score of ≥ 24; and 3) have no current psychotic disorder (as 
determined by the SCID-IV Psychotic Disorder Screener). Eligible participants were 
recruited for this study no sooner than 72 hours after entry in the facility (to limit the 
possible interference of withdrawal symptoms on study engagement). Those who met 
inclusion criteria were provided with information about study procedures and associated 
risks, following which written informed consent was obtained. Participants were reimbursed 
$25 for the assessment session.
Results
Preliminary Analyses
Clinical descriptive data for all participants is presented in Table 1. Based on the MINI, 26% 
(n = 53) of participants met criteria for a current diagnosis of MDD, 65% (n = 133) met 
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criteria for a lifetime diagnosis of MDD, 37% (n = 76) reported a history of NSSI, and 25% 
(n = 50) reported having attempted suicide at least one time in in the past.
Prior to conducting primary analyses, in order to identify potential covariates (see 
Tabachnick & Fidell, 2007), a series of correlation and chi-square analyses were conducted 
to explore associations between the dependent variables (suicide risk and suicide attempt 
history) and demographic (i.e., age, racial/ethnic background, income, education level, and 
marital status) and clinical (i.e., presence vs. absence of current anxiety disorders, current 
substance use disorders, borderline personality disorder, and psychotropic medication use) 
characteristics. Given the small number of participants in many of the demographic 
categories, these variables were collapsed into dichotomous variables of: (1) White (61%) 
versus non-White (39%); (2) past year income of < $20,000 (67%) versus ≥ $20,000 (33%); 
(3) a high school education or less (61%) versus some post-high school education (39%); 
and (4) single (76%) versus married (24%).
Current opioid dependence (r = .16, p < .05), cocaine dependence (r = .15, p < .05), 
hallucinogen dependence (r = .35, p < 001), generalized anxiety disorder (r = .28, p < .001), 
marital status (r = −.14, p < .05), education (r = .15, p < .05), and use of psychotropic 
medications (r = .18, p < .01) were found to be significantly associated with suicide risk. 
Consequently, these variables were included in analyses examining suicide risk as a 
dependent variable. Current opioid dependence (χ2 = 5.21, p < .05), generalized anxiety 
disorder (χ2 = 7.63, p < .01), borderline personality disorder (χ2 = 8.63, p < .01), racial/
ethnic background (χ2 = 4.85, p < .05), education (χ2 = 6.07, p < .05), and use of 
psychotropic medications (χ2 = 16.59, p < .001) were found to be significantly associated 
with having attempted suicide at least once in the past. Thus, these variables were included 
in analyses examining lifetime suicide attempt history as a dependent variable. No other 
significant relations emerged (ps > 0.05).
Primary Analyses
To test our first hypothesis, we conducted a 2 (current MDD vs. no current MDD) × 2 
(lifetime NSSI vs. no NSSI) analysis of covariance (ANCOVA; controlling for opioid 
dependence, cocaine dependence, hallucinogen dependence, generalized anxiety disorder, 
marital status, education, and use of psychotropic medications), with our adjusted suicide 
risk variable serving as the dependent variable (see Table 2 for sample size and mean suicide 
risk levels across all groups). Results revealed significant main effects of current MDD, 
F(1, 193) = 12.53, p < .001, ηp2 = .06, and lifetime NSSI, F(1, 193) = 4.71, p < .05, ηp2 = .02. 
As hypothesized, these main effects were qualified by a significant interaction, F(1, 193) = 
5.58, p < .02, ηp2 = .03. Tukey HSD post-hoc analyses demonstrated that participants with 
current MDD and a history of NSSI exhibited significantly higher levels of suicide risk 
relative to all other groups (ps < .01). No other comparisons were significant (see Figure 1).
Next, we conducted a hierarchical logistic regression to examine whether lifetime NSSI and 
lifetime MDD interact to predict lifetime suicide attempt status. The covariates of opioid 
dependence, generalized anxiety disorder, borderline personality disorder, racial/ethnic 
background, education, and use of psychotropic medications were entered in the first step of 
the model, followed by lifetime NSSI and lifetime MDD in the second step of the model and 
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the lifetime MDD by lifetime NSSI interaction in the third step of the model. Lifetime 
suicide attempts (yes vs. no) served as the dependent variable. The overall model was 
significant, χ2(9) = 37.76, p < .001, accounting for 25% of the variance in lifetime suicide 
attempts. However, only lifetime NSSI emerged as a significant predictor of lifetime suicide 
attempts above and beyond the covariates. Further, the step including lifetime NSSI was 
found to significantly improve the model, accounting for an additional 5% of the variance in 
lifetime suicide attempt history above and beyond covariates and MDD, χ2(2) = 7.11, p < .05 
(see Table 3).
Given documented concerns about the use of covariates in analyses (see Miller & Chapman, 
2001), we reran analyses without the inclusion of covariates. Results did not change. In 
analyses examining current suicide risk, results revealed significant main effects of current 
MDD, F(1, 200) = 10.92, p < .001, ηp2 = .05, and lifetime NSSI, F(1, 200) = 10.27, p < .01, ηp2 
= .05, as well as a significant MDD by NSSI interaction, F(1, 200) = 5.55, p < .02, ηp2 = .03. 
Further, Tukey HSD post-hoc analyses demonstrated that participants with current MDD and 
a history of NSSI exhibited significantly higher levels of suicide risk relative to all other 
groups (ps < .01). Likewise, only lifetime NSSI emerged as a significant predictor of 
lifetime suicide attempts, accounting for 9% of the variance in lifetime suicide attempts, 
χ2(2) = 13.62, B (SE) = 1.12 (.34), Wald = 11.06, OR = 3.07, 95% Confidence Interval = 
1.55–5.95, p < .001.
Discussion
The aim of the present study was to examine the interactive effects of both current MDD and 
lifetime NSSI on current suicide risk and lifetime MDD and lifetime NSSI on past suicidal 
behavior within a high-risk sample of SUD patients in residential treatment. As predicted, 
we found a significant interaction of current MDD and lifetime NSSI on current suicide risk. 
Specifically, relative to all other groups of participants, participants with current MDD and a 
history of NSSI exhibited the greatest levels of suicide risk. These findings are consistent 
with past research underscoring the importance of co-occurring depression and NSSI in 
suicidality (Muehlenkamp & Gutierrez, 2007), and expand upon extant research 
demonstrating that MDD and NSSI are unique risk factors for suicidal behavior (Kessler et 
al., 2005; Neeleman, 2001; Nock et al., 2010; Guan et al., 2012; Tang et al., 2011; Wilkinson 
et al., 2011).
Our results are also consistent with the IPTS (Joiner, 2005), as well as Klonsky and May’s 
(2015) ideation-to-action model. Specifically, according to the IPTS (Joiner, 2005), a desire 
to die is not sufficient for determining suicide risk. Likewise, Klonsky and May (2015) 
suggest that the experience of pain, hopelessness, and a lack of connectedness may 
contribute to suicidal ideation but not necessarily risk for enacting lethal self-harm. Instead, 
according to both of these models, a key factor in establishing suicide risk is the presence of 
the acquired capability for making a suicide attempt (Joiner, 2005; Klonsky & May, 2015). 
The results of the current study support these theories by suggesting that it is the joint 
presence of both a desire to die (as experienced in a depressive episode) and the acquired 
capability for suicide (which can be attained through a history of NSSI) that places 
individuals at the highest risk for suicide, above and beyond lifetime NSSI or current MDD 
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alone (Joiner, 2005). Notably, there were no significant differences in current suicide risk 
between participants with a history of NSSI alone and those with current MDD alone, 
suggesting that these factors may contribute equally to current suicide risk.
The results of this study also revealed a main effect of lifetime NSSI on lifetime suicide 
attempts, highlighting the particular relevance of NSSI to suicidal behavior. This finding is 
consistent with past research on the common co-occurrence of these behaviors (Asarnow et 
al., 2011; Bryan, Bryan, May, & Klonsky, 2014; Klonsky et al., 2013; Klonsky & 
Muehlenkamp, 2007; Nock et al., 2006), and adds to the literature on NSSI as a major risk 
factor for suicidal behavior. Indeed, Klonsky et al. (2013) found that NSSI was a robust 
predictor of suicide attempts (second only to suicidal ideation) across four different samples: 
adolescent psychiatric inpatients, adolescent high school students, university undergraduate 
students, and a sample of community adults in the United States. Likewise, in a recent study 
of military personnel and veterans, Bryan et al. (2014) found that 41% of those with a past 
suicide attempt had a history of NSSI, and NSSI preceded suicide attempts in 91% of the 
cases.
Conversely, lifetime MDD alone did not emerge as being associated with lifetime suicide 
attempts, suggesting that a history of MDD in and of itself may not increase risk for suicide 
attempts. Consistent with this finding, studies have shown that depression severity is 
associated with suicidal ideation (Genischen et al., 2010; Keilp et al., 2012) but not suicide 
attempts (e.g., van Gastel et al., 1997). Thus, although worsening depression symptoms may 
increase the desire to end one’s life, these symptoms in and of themselves may not actually 
increase the risk for suicidal behaviors in the absence of additional risk factors (other than 
NSSI). That said, it is important to consider that the absence of a significant relation 
between lifetime MDD and suicide attempts in this study may also be due to limitations in 
our assessments. Specifically, our data did not allow us to determine whether a suicide 
attempt occurred in the context of or in proximity to a past major depressive episode. Given 
this, longitudinal studies are needed that explore the specific interplay of risk factors that 
may increase the likelihood that an individual with MDD attempts suicide.
There are several limitations to the present study that warrant discussion. First, the present 
study relied on a cross-sectional design, requiring a focus on current suicide risk and past 
suicide attempts rather than future engagement in suicidal behavior. As such, future 
prospective research should examine the utility of the proposed model in predicting future 
suicide attempts. Likewise, it is important to note that the IPTS focuses specifically on lethal 
and nearly lethal suicidal behavior, so the use of an outcome variable in one of our analyses 
that includes suicidal ideation, suicide plans, and related non-behavioral variables is a 
deviation from the initial purpose of this theoretical framework. In addition, given our focus 
on SUD patients, it is unclear whether these findings would be generalizable to other clinical 
or nonclinical populations. Nonetheless, given evidence that substance use and dependence 
are important risk factors for both suicide attempts and death by suicide (Beautrais et al., 
1996; Cheng et al., 2000; Nock et al., 2009), SUD patients are an important population for 
examining suicide risk. Furthermore, although we controlled for the presence of other 
psychiatric disorders, future studies would benefit from examining whether the presence of 
certain psychiatric disorders influence or moderate the relation between MDD, NSSI, and 
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suicide risk and/or attempts. One disorder in particular that may be worthwhile to examine 
in this regard is borderline personality disorder, given its frequent co-occurrence with MDD 
(Zanarini et al., 1998), NSSI (Gunderson, 2001; Soloff, Lis, Kelly, Cornelius, & Ulrich, 
1994), and suicidal behavior (Soloff et al., 1994).
Additionally, it warrants mention that IPTS constructs were not measured directly in these 
analyses. Thus, the constructs of interest in this study may be capturing other components of 
the IPTS, or other risk factors for suicide not specified in the IPTS. For example, although 
the IPTS suggests that NSSI may increase the risk for suicide by increasing the acquired 
capability for suicide, there may be other reasons why NSSI is associated with suicide risk 
and/or attempts. NSSI is associated with elevated levels of shame, self-criticism, and 
feelings of inferiority (Gilbert et al., 2010), and past research indicates that shame and self-
punishment motives are a major contributing factor in an individual’s decision to attempt 
suicide (Brown, Comtois, & Linehan, 2002; Hastings, Northman, & Tangney, 2000; Lester, 
1998). Alternatively, the experience of loss of control that accompanies chronic and 
escalating NSSI may contribute directly to suicide risk, as the individual feels helpless to 
control the behavior (Buser & Buser, 2013; Groschwitz & Plener, 2012). Future research 
that directly tests the role of these and other factors in the model tested here would increase 
confidence in our current interpretation of the results. Finally, as with all interview-based 
and self-report measures, some participants may have been unwilling to report on their 
history of NSSI and suicide attempts and current suicidal thoughts and ideation due to 
concerns about stigma and social desirability. To address this limitation, future studies 
should include alternative methods of assessment capable of overcoming the interference of 
these factors in the assessment of suicidal thoughts and behaviors (e.g., implicit association 
tasks; see Nock & Banaji, 2007).
Despite these limitations, the findings from the present study suggest important directions 
for clinical assessment and intervention. In particular, these findings underscore the 
importance of assessing for both lifetime NSSI and current MDD when determining current 
suicide risk. Indeed, our results suggest that it may be the combination of these factors, 
relative to either alone, that increases suicide risk in SUD patients. These findings also 
highlight the potential utility of interventions targeting both depression and NSSI for 
reducing suicide risk in SUD patients. In particular, behavioral activation has demonstrated 
efficacy in reducing depression among SUD patients in residential treatment (Daughters et 
al., 2008). Emotion regulation group therapy for deliberate self-harm (Gratz & Gunderson, 
2006; Gratz, Tull, & Levy, 2014) may also be useful in reducing NSSI and symptoms of 
depression through the improvement of emotion regulation skills. Results of the current 
study highlight the potential utility of incorporating these or related interventions into 
residential SUD treatment in order to decrease suicide risk among this at-risk population.
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The interactive effect of current MDD and lifetime NSSI on suicide risk (controlling for 
opioid dependence, cocaine dependence, hallucinogen dependence, generalized anxiety 
disorder, marital status, education, and psychotropic medication use).
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Table 1
Clinical and Diagnostic Characteristics of Participants.
% Present (n)
Lifetime Major Depression 65.2% (133)
Major Depression 26% (53)
Panic Disorder 26% (53)
Social Anxiety Disorder 25% (51)
Obsessive-Compulsive Disorder 13.2% (27)
Generalized Anxiety Disorder 30.4% (62)
Posttraumatic Stress Disorder 26% (53)
Alcohol Dependence 66.7% (136)
Cocaine Dependence 57.8% (118)
Opioid Dependence 24% (49)
Marijuana Dependence 28.9% (59)
Sedative Dependence 20.6% (42)
Stimulant Dependence 21.1% (43)
Hallucinogen Dependence 3.4% (7)
Borderline Personality Disorder 34.8% (71)
Lifetime Nonsuicidal Self-injury 37.3% (76)
Lifetime Suicide Attempt 27% (50)
Psychotropic Medication Use 51% (104)
Note. All psychiatric disorders presented are current diagnoses unless noted otherwise.
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Table 2
Means, standard deviations, and sample size for suicide risk across all groups
No Current MDD Current MDD








Note. Non-adjusted means are presented. Standard deviations are presented in parentheses. MDD = major depressive disorder. NSSI = nonsuicidal 
self-injury. Means that do not share superscripts are significantly different according to Tukey HSD post-hoc tests.
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Table 3
Binomial Logistic Regression Examining Lifetime MDD and DSH as Predictors of Lifetime Suicide Attempts
B (SE) Wald OR 95% CI
Step 1
 Opioid Dependence .63 (.40) 2.48 1.88 0.86–4.12
 Generalized Anxiety Disorder .48 (.39) 1.52 1.61 0.75–3.45
 Borderline Personality Disorder .68 (.38) 3.14 1.97 0.93–4.15
 Racial/Ethnic Background −.01 (.43) .001 0.99 0.43–2.28
 Education .36 (.37) .93 1.43 0.69–2.93
 Psychotropic Medication Use 1.25 (.40) 9.62 3.48 1.58–7.64
Step 2
 Lifetime MDD .26 (.41) .42 1.30 0.59–2.87
 Lifetime NSSI .97 (.38) 6.52* 2.63 1.25–5.52
Step 3
 Lifetime MDD × Lifetime NSSI .59 (.57) 1.07 1.80 0.59–5.43
Note. MDD = lifetime major depressive disorder. NSSI = nonsuicidal self-injury. OR = Odds Ratio. CI = Confidence Interval.
*
p < .05.
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